000 | 01959 a2200493 4500 | ||
---|---|---|---|
005 | 20250516100308.0 | ||
264 | 0 | _c20120726 | |
008 | 201207s 0 0 eng d | ||
022 | _a0003-4894 | ||
024 | 7 |
_a10.1177/000348941212100502 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBanks, Caroline A | |
245 | 0 | 0 |
_aRecurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature. _h[electronic resource] |
260 |
_bThe Annals of otology, rhinology, and laryngology _cMay 2012 |
||
300 |
_a291-5 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 |
_aAirway Obstruction _xetiology |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBronchoscopy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aEpstein-Barr Virus Infections _xcomplications |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 |
_aHerpesvirus 4, Human _xisolation & purification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunocompromised Host |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 |
_aLarynx _xpathology |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 |
_aTrachea _xpathology |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMeier, Jeremy D | |
700 | 1 | _aStallworth, Christina R | |
700 | 1 | _aWhite, David R | |
773 | 0 |
_tThe Annals of otology, rhinology, and laryngology _gvol. 121 _gno. 5 _gp. 291-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/000348941212100502 _zAvailable from publisher's website |
999 |
_c21887470 _d21887470 |